share_log

HC Wainwright & Co. Reiterates Buy on Collegium Pharmaceutical, Maintains $50 Price Target

Benzinga ·  Mar 24 12:08

HC Wainwright & Co. analyst Oren Livnat reiterates Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and maintains $50 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 207

Recommended

Write a comment